SV Pharma

Ottignies-Louvain-la-Neuve ·KBO/BCE: BE 0767.715.111

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	17-01-2026	14 d early	2026-00009941
30-06-2024	31-01-2025	17-01-2025	14 d early	2025-00006395
30-06-2023	31-01-2024	12-01-2024	19 d early	2024-00000879
30-06-2022	31-01-2023	30-01-2023	1 d early	2023-00009892

Metric	This company	Sector median	Position in the sector
Solvency	27.0%	55.4%	better than 23% of 216 sector peers
Net result	€61k	€65k	better than 49% of 216 sector peers
Equity	€220k	€3.31M	better than 24% of 216 sector peers
Gross operating margin	€6k	€48k	better than 24% of 101 sector peers
Employees (FTE)	0.0	3.6	better than 10% of 55 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€815k
Fixed assets	21/28	€741k
Formation expenses	20	€2k
Tangible fixed assets	22/27	€1k
Financial fixed assets	28	€739k
Current assets	29/58	€72k
Amounts receivable within one year	40/41	€47k
Cash & bank	54/58	€8k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€815k
Equity	10/15	€220k
Contributions / capital	10/11	€50k
Reserves	13	€170k
Amounts payable	17/49	€594k
Amounts payable after one year	17	€537k
Amounts payable within one year	42/48	€57k
Trade debts payable within one year	44	€6k
Income statement
Gross operating margin	9900	€6k
Operating result	9901	€3k
Financial income	75	€70k
Financial charges	65	€6k
Result before taxes	9903	€68k
Income taxes	67/77	€6k
Net result for the period	9904	€61k
Result to be appropriated	9905	€61k

Summary